Indave, Blanca I and Minozzi, Silvia and Pani, Pier Paolo and Amato, Laura (2016) Antipsychotic medications for cocaine dependence. Cochrane Database of Systematic Reviews, (3), DOI: 10.1002/14651858.CD006306.pub3.
External website: http://onlinelibrary.wiley.com/doi/10.1002/1465185...
Key results: The studies used different instruments or ways to assess the outcomes of interest, limiting the possibility for us to combine the data. When we grouped together all trial results comparing any antipsychotic drug to placebo, we found that antipsychotics slightly increase those who stayed in treatment but they were not effective in reducing cocaine use during treatment (two studies), in sustained abstinence (three studies), or in reducing the urge to consume cocaine (four studies). The single comparisons of each drug versus placebo or versus another drug were made in few trials with small sample sizes, limiting the reliability of the results. However, among these comparisons, only quetiapine seemed to perform better than placebo in reducing cocaine use and craving, but results came only from one study with 60 participants. Information was limited on the acceptability of treatment in terms of side effects, abstinence from cocaine use and withdrawal symptoms. Overall we found no evidence supporting the clinical use of antipsychotic medications in the treatment of cocaine dependence.
[Click URL above for full text. See also, Drug and Alcohol Findings article, 17 October 2016 http://findings.org.uk/PHP/dl.php?file=Indave_BI_1.cab&s=]
HJ Treatment or recovery method > Substance disorder treatment method > Substance disorder drug therapy (pharmacological treatment)
HJ Treatment or recovery method > Treatment outcome
J Health care, prevention, harm reduction and treatment > Health care administration > Health care quality control
VA Geographic area > International
Repository Staff Only: item control page